Paul Newman, PHD | |
Department Of Defense, Wrnmmc, Bldg 19 Fl 6 Rm6131, 4954 North Palmer Road, Apo, AA 20889-5630 | |
(301) 400-1955 | |
Not Available |
Full Name | Paul Newman |
---|---|
Gender | Male |
Speciality | Clinical Neuropsychologist |
Location | Department Of Defense, Wrnmmc, Bldg 19 Fl 6 Rm6131, Apo, Armed Forces Americas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336120765 | NPI | - | NPPES |
2514587 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 5774 (Ohio) | Secondary |
103G00000X | Clinical Neuropsychologist | 5774 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Paul Newman, PHD Department Of Defense, Wrnmmc, Bldg 19 Fl 6 Rm6131, 4954 North Palmer Road, Apo, AA 20889-5630 Ph: (301) 400-1955 | Paul Newman, PHD Department Of Defense, Wrnmmc, Bldg 19 Fl 6 Rm6131, 4954 North Palmer Road, Apo, AA 20889-5630 Ph: (301) 400-1955 |
News Archive
A survey in the latest issue of the Hastings Center Report found that most hospices in Oregon, the first state to legalize physician-assistance in dying, either do not participate in or have limited participation in requests for such assistance. Both legal and moral reasons are identified.
The body's natural inflammatory response is an essential reaction to injury and infection. When acute inflammation escalates out of control, such as in sepsis, it causes nearly 10% of deaths in the U.S. and more than $17 billion in healthcare costs each year. A group of researchers have developed a groundbreaking biohybrid device that can control acute inflammation to prevent sepsis and other related life-threatening complications, as described in an article in the inaugural issue of Disruptive Science and Technology.
Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, and collaborators will be presenting five studies demonstrating how Adaptive's high-throughput sequencing platform enables diagnosis, detection and assessment of prognosis in hematological malignances and has increased sensitivity over flow cytometry.
Researchers led by Professor Jun-Fen Lin at Zhejiang Provincial Center for Disease Control and Prevention have found that reproductive history, an important modifier of estrogen exposure across women's lifetime, is associated with risk of cognitive impairment in postmenopausal women.
Researchers at The University of Chicago have demonstrated that the type of bacteria living in the gut can influence the development of Alzheimer's disease symptoms in mice.
› Verified 1 days ago